To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC77935 | Movronersen |
Movronersen is an antisense oligonucleotide targeted to α-synuclein.
More description
|
|
| DC77934 | Movronersen sodium |
Movronersen sodium is an antisense oligonucleotide targeted to α-synuclein.
More description
|
|
| DC77933 | Mivelsiran |
Mivelsiran is a siRNA targeted to amyloid-beta precursor protein (APP). It is used for the study of Alzheimer's disease.
More description
|
|
| DC77932 | Mivelsiran sodium |
Mivelsiran sodium is a siRNA targeted to amyloid-beta precursor protein (APP). It is used for the study of Alzheimer's disease.
More description
|
|
| DC77931 | Lufepirsen |
Lufepirsen is an unmodified antisense oligonucleotide targeted to Connexin43 (Cx43). Connexin43 is a specific protein in the eye, which plays a role in wound healing.
More description
|
|
| DC77930 | Lufepirsen sodium |
Lufepirsen sodium is an unmodified antisense oligonucleotide targeted to Connexin43 (Cx43). Connexin43 is a specific protein in the eye, which plays a role in wound healing.
More description
|
|
| DC77929 | Lixadesiran |
Lixadesiran is a siRNA in STP705. It targets to COX-2. STP705 is composed of 2 siRNA oligonucleotides (Pixofisiran and Lixadesiran) that individually target TGF-β1 and COX-2 mRNA.
More description
|
|
| DC77928 | Lixadesiran sodium |
Lixadesiran sodium is a siRNA in STP705. It targets to COX-2. STP705 is composed of 2 siRNA oligonucleotides (Pixofisiran and Lixadesiran) that individually target TGF-β1 and COX-2 mRNA.
More description
|
|
| DC77925 | Lexaptepid Pegol |
Lexaptepid Pegol is a pegylated structured L-oligoribonucleotide. It binds and inhibits hepcidin.
More description
|
|
| DC77924 | Lexaptepid Pegol sodium |
Lexaptepid Pegol sodium is a pegylated structured L-oligoribonucleotide. It binds and inhibits hepcidin.
More description
|
|
| DC77916 | IAN-15B |
IAN-15B has high selectivity and potent ST6GAL1 inhibitors (IC50 = 3.3 μM). IAN-15B has significant anti migratory and anti angiogenic effects. IAN-15B can be used in the research of cancer such as breast cancer.
More description
|
|
| DC77915 | PBD dimer-4 |
PBD dimer-4 (Compound 7) is a C1-subsitituted PBD dimer. PBD dimer-4 has high DNA-binding affinity, DNA cross-linking ability and potent cytotoxicity against MDA-MB-231 cells (IC50: 236 nM). PBD dimer-4 can be used as a payload of ADC Loncastuximab tesirine to treat several different cancer types.
More description
|
|
| DC77911 | D-CS319 |
D-CS319 is a potent inhibitor of metallo-𝛽-lactamases (MBLs) with IC50 values of 2.0 and 3.0 μM for IMP-1 and IMP-78, respectively. D-CS319 has antibacterial activity.
More description
|
|
| DC77910 | ADEP-14 |
ADEP-14 is a bacterial ClpP activator with EC50s of 0.46 and 3.67 μM for Neisseria meningitides ClpP (NmClpP) and Escherichia coli ClpP (EcClpP). ADEP-14 binds to ClpP H sites and activates the protease. ADEP-14 has antibacterial activity. ADEP-14 can be used for bacterial infections research.
More description
|
|
| DC77902 | Gatuzosiran |
Gatuzosiran, a siRNA,is a 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) synthesis reducer. It is used for the study of fatty liver disease.
More description
|
|
| DC77901 | Gatuzosiran sodium |
Gatuzosiran sodium, a siRNA,is a 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) synthesis reducer. It is used for the study of fatty liver disease.
More description
|
|
| DC77900 | Gataparsen |
Gataparsen is an antisense oligonucleotide directed against survivin mRNA with potential antitumor activity.
More description
|
|
| DC77899 | Gataparsen sodium |
Gataparsen sodium is an antisense oligonucleotide directed against survivin mRNA with potential antitumor activity.
More description
|
|
| DC77898 | GalNac-siRNA negative control (21nt) |
GalNac-siRNA negative control (21nt) is the negative control form of GalNac-siRNA. GalNac-siRNA is an Asialoglycoprotein receptor (ASGPR)-targeted inhibitor conjugate. GalNac-siRNA is promising for research of hereditary transthyretin amyloidosis, acute hepatic porphyria, hemophilia and hypercholesterolemia.
More description
|
|
| DC77897 | Etidaligide |
Etidaligide, an AsiDNA, a first-in-class DNA repair inhibitor designed to prevent the repair of DNA damage in tumour cells. It also activates DNA-dependent protein kinase (DNA-PK) and poly (ADP-ribose) polymerase enzymes that induce phosphorylation of H2A
More description
|
|
| DC77896 | Etidaligide sodium |
Etidaligide sodium, an AsiDNA, a first-in-class DNA repair inhibitor designed to prevent the repair of DNA damage in tumour cells. It also activates DNA-dependent protein kinase (DNA-PK) and poly (ADP-ribose) polymerase enzymes that induce phosphorylation
More description
|
|
| DC77895 | Erisonersen |
Erisonersen, an antisense oligonucleotide, is a prion protein synthesis reducer. It is used for the study of Prion disease.
More description
|
|
| DC77894 | Erisonersen sodium |
Erisonersen sodium, an antisense oligonucleotide, is a prion protein synthesis reducer. It is used for the study of Prion disease.
More description
|
|
| DC77893 | Edutirsen |
Edutirsen, an antisense oligonucleotide, is a 1-acylglycerol-3-phosphate O-acyltransferase (PNPLA3) synthesis reducer.
More description
|
|
| DC77892 | Edutirsen sodium |
Edutirsen sodium, an antisense oligonucleotide, is a 1-acylglycerol-3-phosphate O-acyltransferase (PNPLA3) synthesis reducer.
More description
|
|
| DC77891 | Edifoligide |
Edifoligide is a decoy oligonucleotide that binds to and inhibits E2F transcription factors and thus may prevent neointimal hyperplasia and vein graft failure
More description
|
|
| DC77890 | Edifoligide sodium |
Edifoligide sodium is a decoy oligonucleotide that binds to and inhibits E2F transcription factors and thus may prevent neointimal hyperplasia and vein graft failure
More description
|
|
| DC77887 | DNMT1 aptamer sodium |
DNMT1 aptamer sodium is a DNA aptamer for binding and inhibition of DNA methyltransferase 1 (DNMT1).
More description
|
|
| DC77886 | Diranersen |
Diranersen, an antisense oligonucleotide, is a tau protein synthesis reducer. It is used for the study of Alzheimer's disease.
More description
|
|
| DC77885 | Diranersen sodium |
Diranersen sodium, an antisense oligonucleotide, is a tau protein synthesis reducer. It is used for the study of Alzheimer's disease.
More description
|
|